"You an... we allocate focus internally, highlight our respective advantages, and then support each other?" Sato understood the idea.
"Exactly." Schneider nodded, "For instance, Sato can promise a 30% reduction in production costs during the application, and we will publicly support this plan; we promise to establish six regional training centers in Europe, and you express willingness to adopt unified training standards. This way, it’s hard for Ruixing to pressure one company to suppress another."
"But we’re still competitors." Thompson frowned.
"In terms of the final cooperation qualifications, yes, but in creating the cooperation frawork, we can be allies." Schneider said, "More importantly, we need to jointly pressure Ruixing for more reasonable comrcial terms. The inclusive frawork is acceptable, but the proportion of licensing fees, data ownership, regional exclusivity protection period... these all need negotiation space, gentlen, our pursuit of cooperation is with determination, but let’s strive for so favorable terms."
The room fell silent for a mont as the delegates individually pondered.
"I agree with this approach." For the first ti, the UK representative spoke, "But we need a more specific agreent. For example, if one company obtains the authorization for a certain region, it provides necessary channel support when other companies enter adjacent markets. Also, in terms of technology training and quality control standards, we establish a sharing chanism."
"This requires legal docunts." Another representative reminded.
"First reach a gentlen’s agreent, and then once the cooperation qualifications are determined, refine it." Schneider said, "What we’re short of now is ti. Ruixing will start accepting formal applications next week, with an evaluation period of only three months. We must prove three things to Huang Jiacai within these three months: First, cooperating with us is the most efficient choice; Second, if we unite, we also have the ability to create trouble for Ruixing. Third, choosing to cooperate with those small and dium-sized enterprises or allowing BG’s giants to monopolize is not the best choice."
"Create trouble?" Dupont raised an eyebrow.
Schneider lowered his voice: "I’ve received information that there’s dissatisfaction within the European Pharmaceutical Agency regarding the ’data sharing’ clause of the inclusive frawork, believing it may lead to European patient data flowing to China. If we push for relevant hearings in the European Parliant..."
"That’s too risky." A representative imdiately objected, "It would escalate comrcial negotiations into geopolitical confrontations, potentially backfiring."
"It’s just a backup plan." Schneider said, "The premise is that Huang Jiacai completely denies us reasonable comrcial space. But now it seems, he’s more astute and stubborn than we imagined. He’s an extrely clever opponent."
Thompson suddenly laughed: "Gentlen, have we overlooked the simplest question—why do we need to accept this frawork? Why can’t we jointly develop alternative technology?"
The room fell silent again, this was a thought everyone had considered but dared not easily voice again.
"What I an is, we can use developing alternatives as a bargaining chip, not actually do it. Of course, cooperating now is rely temporary, soday we will develop alternatives." Thompson was emphatic.
"Your idea is good, but don’t forget, they understand alternative solutions better than we do, ti is simply running out." Dr. Moro finally spoke, this scientist representative had been silent, "I’ve consulted our company’s top gene therapy team. Their assessnt is: even if we start now, invest five billion dollars, to replicate the technology path of K Therapy, it will take at least five years. And to verify safety, efficacy, complete clinical trials, and gain approval, it will take another five years."
She looked around: "What will the market be like in ten years? What generation will Ruixing’s technology iterate to? Can we afford to wait? Huang Jiacai is more aware than us, frankly, although his educational background seems poor, he knows technology better than you do, based on this, we don’t have much room for maneuver in this negotiation, you can’t compete with him."
The harsh reality left everyone silent. This is the most terrifying aspect of technological generation gap—it’s not rely product advantage, but the entire technological route’s lead. The ti required to catch up is enough for the leader to establish almost insurmountable barriers.
"Let it be decided then." Schneider finally said, "We coordinate positions during the application stage, striving for optimal terms. But each maintains independent application, the final cooperation qualifications are up to one’s abilities. anwhile, initiate pre-research on alternative technology, even if just as a bargaining chip."
No voting, no signatures, but consensus was reached. Six hands stretched towards the center of the round table one after another, overlapping together—a brief and fragile alliance, reconvening in the face of interests.
What they didn’t know was that the confidentiality signal jamr in the hotel suite hadn’t completely blocked Ruixing’s security team’s latest eavesdropping devices. In an office building three kiloters away, Huang Jiacai’s assistant took off the noise-canceling headphones, quickly sorting through the content summary just listened to.
Five minutes later, this summary appeared in Huang Jiacai’s encrypted email inbox.
On the twentieth day of Li Gaoyang’s treatnt, Sanbo Hospital received the first ordinary patient under the inclusive frawork.
Not a tycoon, not a celebrity, not even with comrcial insurance. Her na is Li Xiaoyun, a 42-year-old primary school teacher, mother of two children. Three months ago, diagnosed with glioblastoma, Grade IV, the doctor pronounced a survival period of no more than six months.
She qualified through the newly launched "Global K Therapy Patient Application Platform," which prioritizes dostic patients and then gradually opens to the world.
This platform is designed under the inclusive frawork, completely transparent: patients submit dical records, the system automatically evaluates the severity of the illness and treatnt necessity, then arranges according to waiting ti. There’s no human intervention, no paynt ability review—because, according to the frawork, patients lacking paynt ability will receive assistance from the global treatnt fund.
Li Xiaoyun’s husband Wang Jianjun, an ordinary engineer, squatted in the hospital corridor crying for ten minutes upon learning his wife qualified for treatnt. They had sold their hotown house, borrowed from relatives and friends everywhere, and were originally prepared to give up, accept the cruel survival prediction.
Now, they were arranged in the ordinary ward of the Sanbo Research Institute, Yang Ping personally ca for inspection.
"Teacher Li, I am Yang Ping." He spoke gently, "This afternoon we will begin the first phase of treatnt. The entire process will take about six weeks, during which you need to be hospitalized, you can ask any questions at any ti."
Li Xiaoyun was very weak, but her eyes were bright: "Professor Yang... I heard this treatnt is very expensive, and this new therapy can’t be recognized by insurance companies temporarily because it’s currently in the clinical trial phase."
"According to the inclusive frawork, your treatnt fee is calculated based on the proportion of your family annual inco. The inco proof your husband submitted shows that you need to bear 10% of the total costs, the rest will be covered by dical insurance and the global treatnt fund."
"Then... how much is it?"
Yang Ping glanced at the dical record: "Your total treatnt fee assessnt is 800,000 RMB, you need to pay 80,000."
Wang Jianjun was stunned: "An 800,000 RMB treatnt, we only pay 80,000?"
"Yes, this is the significance of the inclusive frawork—to make technology benefit those who truly need it, not just those who can afford the full price."
The couple exchanged a look, tears flowed again, this ti tears of hope.
At 2 p.m., the treatnt began. Unlike the personalized customization for Li Gaoyang, Li Xiaoyun used standardized viral vectors, reducing production costs by 70%, making inclusivity possible.
In the ward, Song Zimo and Xu Zhiliang were in charge of the entire treatnt, they were already very proficient.
User Comments
0 comments from readers